Submission

Published in Conference
Monday, 21 October 2019 10:25
2820 Hit
(1 Vote)

MSA University - Resilience International Conference

    

Early Submission

* Paper submission and registration for attendance is closed
Registration Form

Late Submission

* Paper submission and registration for attendance is closed
Registration Form

Registration for Attendance

* Paper submission and registration for attendance is closed
Registration Form

The Path to City Resilience International Conference

Published in Conference
Wednesday, 07 August 2019 10:46
6918 Hit
(2 votes)

MSA University - Resilience International Conference

Introduction:
All cities are vulnerable to severe impacts from a range of shocks and stresses that can be both natural and human made. Resilience challenges could be a result of rapid urbanization, climate change, political or economical instability. Resilience is the ability of urban systems to maintain continuity through all pressures and strains while positively adapting and transforming towards sustainability. A resilient city assesses, plans and acts to prepare to absorb, respond to and recover from all hazards, either sudden or slow-onset, expected or unexpected while maintaining its essential functions, structures and identity and adapting to continual changes. Consequently, resilient cities have the ability to protect and enhance people’s lives, secure development gains, foster an investible environment, and drive positive change. Unplanned cities are more vulnerable to shock as they often have pre-existing stresses. In cities that are not prepared or unable to recover, shocks can intensify existing stresses and create a flow of negative impact that compromise city functionality and put people at risk. The fundamental aspect is how cities should protect their cultural and natural heritage to adapt to climate change without losing their identity.

Main Themes:
CONFERENCE PURPOSE:

 

This conference will be a chance to find new solutions and innovations in the resilient urban systems. These creative inventions can be a motive to dynamic, desirable and healthy communities. “The Path to City Resilience” conference is a fertile ground for architects, engineers, city planners, social and political scientists who able to consider new concepts and adapt them according to technological innovations and human desires.

 

1- Urban Resilience:

Urban resilience is the measurable ability of any urban system, with its inhabitants, to maintain continuity through all shocks and stresses, while positively adapting and transforming toward sustainability. Cities and city inhabitants are facing additional challenges as a result of rapid urbanization, a changing climate and political instability. A resilient city assesses, plans, and acts to prepare for and respond to all hazards; sudden and slow-onset, expected and unexpected. As risks and urban population are increasing, urban resilience has gained greater importance in international development discourse and has emerged as one of the core principles of sustainable urban development in the global development frameworks and targets, including sustainable development goals, new urban agenda and agreements on climate change: - Pathways towards implementing resilience.
- Innovation in the realm of urban resilience. New challenges require new solutions. How can innovations in the resilient urban systems be a motive to dynamic, desirable and healthy communities.
- Building cohesive, healthy and resilient community.

2- Resilience Planning:

Resilience planning is a holistic approach that takes into consideration future economic, social and environmental developments including climate change. Planning for resilience empowers diverse stakeholders to evaluate plans, set strategic policies, and implement projects that will enable communities to adapt and succeed when faced with challenges. Resiliency planning can include updating land use codes, zoning, development standards, incentive programs, and other plans or policies to better prepare for shocks and stresses while also developing measures that allow for action in the face of uncertainty or unexpected events.

3- Resilience and Heritage:

Historic cities, monuments, archaeological sites, museums and cultural landscapes are increasingly affected by threats both natural and manmade. The progressive loss of these places as a result of floods, mudslides, fire, earthquakes, civil unrest has become a major concern. Heritage contribute to social cohesion, sustainable development and psychological wellbeing. Protecting heritage promotes resilience. There is a considerable wealth of experience exists in protecting heritage form disasters and in harnessing the potential of a well-maintained historic environment to strengthen the resilience of communities. The initiative and commitment of national and local governments, businesses and communities around the world is increasingly apparent. Their efforts need to be further encouraged. UN Agencies, NGO’s and a wide range of universities and technical institutions have been organizing additional support and guidance. Nevertheless, efforts to protect heritage from disaster risk remain fragmented and efforts to draw on heritage as an instrument for building resilience remain inconsistent. It is essential for cities to protect their cultural and natural heritage to adapt to climate change without losing their identity.

4- Environmental Resilience:

- Climate change is aggravating the intensity and frequency of natural disaster worldwide. How are cities should be ready to cope with environmental risks.

- Examining the ability of natural systems to recover from disturbances and to tolerate or adapt to changing climate.

- Improving our understanding of the risks facing both natural and managed systems as a result of global change factors, such as climate change, land-use change and nutrient pollution.

5- Landscape Resilience:

- Landscape resilience is the ability of a landscape to sustain desired ecological functions, healthy natural biodiversity, and critical landscape processes over time, under changing conditions, and despite multiple stressors and uncertainties. Landscape resilience identifies the factors that create options and alternative for species and processes within places places. The attributes of resilience differ depending on whether the focus is on species and ecosystems or on enduring physical landscape. It is essential to explore the factors that allow a landscape and a geophysical setting to sustain ecological function and maintain a diverse array of species places as the climate changes. Those places with inherent properties that built resilience will be natural strongholds for species and nature into the future. The seven main principles of landscape resilience are setting, process, connectivity, diversity and complexity, redundancy, scale and people.

6- Infrastructure Resilience:

Infrastructure systems are important when considering infrastructure resilience. Resilience is not just related to individual infrastructure elements, but it shows how these work together as energy, transport, water and sanitation, ITC networks – and affect each other. - Climate Change:
- Understanding climate change implications for infrastructure resilience.
- Best practices in infrastructure resilience and enhancing capacity.
- Critical consideration of the role of planning in resilience. - Emergency Planning:
- Understanding acute events and their implications for infrastructure resilience.
- Understanding emergency planning’s role in infrastructure resilience.
- Best practices in emergency planning. - Hard Infrastructure:
- Understanding the fundamentals of infrastructure resilience.
- Best practices in infrastructure resilience and enhancing capacity.
- Critical consideration of the role of planning in resilience.
- Natural areas and cities. - Soft Infrastructure:
- Understanding the fundamentals of infrastructure resilience.

7- Resilience in Systems:

System resilience is an ability of the system to withstand a major disruption within acceptable degradation parameters and to recover within an acceptable time. - Innovative methodologies, smart technologies, techniques and solutions to resilience challenges.

8- Innovative Smart Technologies and Resilience

Innovative applications of smart technologies make cities stronger, improving resources allocation, strengthening communication and social cohesion and generally making life easier for everyone living in the city.

9- Resilience in Education System:

Education resilience involves identifying risks and assets, protecting the assets in schools, universities and communities, and aligning education system commitment to a resilience approach. Resilience matters in education because learning and education can be the vehicle to overcome shocks and stresses.

10- National Policy Frameworks on Resilience:

Collaboration with other levels of government is one of the key drivers to ensure a coherent and integrated approach to resilience. Many national governments have plans for reinforcing their countries’ resilience. Of the 45 national policy frameworks on resilience, 39 mention the role of cities or subnational governments for building national resilience in the national policy frameworks on resilience. They refer to the importance of local actions for resilience by emphasizing that local authorities are primarily responsible for building resilience. Some frameworks on resilience include very specific roles and missions for cities.

 

Contact Us
Address: MSA University, 26th July Mehwar Road Intersection with Wahat Road, 6th of October City, Egypt.

Tel: +202-383-71114/5/6

Fax: +202-383-71543

E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it. - This email address is being protected from spambots. You need JavaScript enabled to view it.

Keynote Speakers

Published in Conference
Sunday, 22 November 2020 12:34
64984 Hit
(2 votes)

MSA University - Pharmacists in Frontlines - Keynote Speakers

Keynote Speakers

Published in Conference
Sunday, 22 November 2020 13:32
3813 Hit
(1 Vote)

Prof. Dr. David M. AronoffProf. Dr. David M. Aronoff, MD is the Director of the Division of Infectious Diseases at the Vanderbilt University Medical Center.
Prof. Aronoff, has been highly involved in the diagnosis and clinical care of COVID-19. He has been a key communicator of public health measures during the pandemic, through frequent media appearances, educational activities across the region, and direct relationships with employers.
You can follow him on Twitter @DMAronoff.
Title: An update on the diagnosis & management of COVID-19

PD Dr Martin FrotscherPD Dr Martin Frotscher, born 1966, studied chemistry at Saarland University, Saarbrücken (Germany).
He received his PhD in Medicinal Chemistry in 1997, in the group of Prof. Dr. R. W. Hartmann.
Having held positions in the pharmaceutical and chemical industry (Menarini, Florence (Italy) and Chemcon, Freiburg i. Br. (Germany)), Dr. Frotscher returned to Saarland University, pursuing his research in steroidogenic enzyme inhibition.
In 2018, Dr. Frotscher completed his habilitation and obtained the venia legendi in Pharmaceutical and Medicinal Chemistry
Title: "Polypharmacology: Multiple Ligands - A Challenge for the Medicinal Chemist"

Dr Simon RichardsonDr Simon Richardson is a cell biologist who has an interest in drug delivery. His PhD was conducted at the UCL School of Pharmacy and he was a postdoc in Iowa USA studying lysosome biogenesis before starting his own research group at Greenwich is 2007.
The focus of his research group is the use of synthetic proteins to manipulate endomembrane for the delivery of siRNA and gene editing machinery. This research focuses on viral disease, cancer and obesity.
Title: Antiviral siRNA Delivery Using Recombinant Proteins and Exosomes.

Dr. Katerina LalatsaDr. Katerina Lalatsa- is a Reader in Nanomedicines and MSc Medical Biotechnology course leader at the School of Pharmacy and Biomedical Sciences, University of Portsmouth (UK).
Her lab is focused on the engineering of peptide and polymer amphiphiles for drug delivery and tissue regeneration and on additive manufacture of nanomedicines.
Title: "Nanomedicines for Brain Diseases and Cancers".
 

Dr. Hazem E. HassanDr. Hazem E. Hassan, PhD, MS, RPh, FCP is an Associate Director at Regeneron Pharmaceutical Inc. and a fellow of the American College of Clinical Pharmacology (ACCP). He oversees a variety of programs including neuroscience, hematology and ophthalmology portfolios. Prior to joining Regeneron, Dr. Hassan served as a Clinical Pharmacologist at the FDA and as an Assistant Professor and Director of the Pharmacokinetics and Biopharmaceutics Lab at University of Maryland where he mentored several PhD students, postdocs and visiting scientists. Dr. Hassan also holds a position as an Associate Professor at Faculty of Pharmacy, Helwan University. He is currently serving on different capacities on several leadership committees of the AAPS, ACCP and ASCPT. He co-authored 45 articles, book chapter and 95 abstracts. His research was supported by several grants from the FDA, NIH and UMB. In recognition of his contributions, Dr. Hassan received several awards from the FDA, AAPS and UMB, and was featured in the CPT journal, Bioanalysis Journal and AAPS News magazine.
Title: “Baloxavir Marboxil: A Novel Antiviral Agent for Treatment of Uncomplicated Influenza”

Dr. Omar AbouelataDr. Omar Abouelata-, MPH, PhD Technical Officer – Surveillance, Preparedness and Response WHO/WRO/Egypt Title: COVID 19 and AMR Common Challenges, Threats, Joint prevention and control activities
 

Dr. Hadeer RostomDr. Hadeer Rostom was a principal contributor in issuing the “Good Pharmacovigilance Practice guidelines in Arab Countries” (GVP-Arab).
She played an important role in strengthening Pharmacovigilance practice in Egypt and integrating pharmacovigilance teaching in Academia. She supervised several pharmacovigilance research projects. Hadir is seen as a strategic pharmacovigilance figure in Egypt and the region.
Title: Safety monitoring for COVID-19 Vaccines

Prof Dr. Rania HathoutProf. Dr. Rania Hathout, currently works as a Professor at the Faculty of Pharmacy, Ain Shams University. Prof. Dr. Rania, does research in Nanomedicine and Drug Delivery, Nanotechnology, Polymer Chemistry, Physical Chemistry and Chemoinformatics.
Her current project is 'Preparation of drug-loaded conducting polymers using electrochemical polymerization - Department of Chemistry and Materials Science Institute - Lancaster University - Lancaster - UK.
Title: " Machine Learning methods in drug delivery "

Dr. Hussien AzmyDr. Hussien Azmy, is leading the Marketing, Medical, Training, Regulatory as well as the New Product and Product Portfolio Planning and Business Development in Egypt, Middle East and Africa
Title: “Rameda Pharmaceuticals: Providing Innovative Solutions to Meet Therapeutic Needs and Challenges”

Dr. Gihan Hamdy El-SisiDr. Gihan Hamdy El-Sisi- Lecturer_Health Economics, Arab Academy for Science & Technology & Cairo University
Health Economics Certificate Scientific Committee, American University in Cairo
Founder and Former Head of Pharmacoeconomic Unit, CAPA, MoH, Egypt
Health Economics Consultant, World Health Organization EMR Office
Treasurer of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Egypt
Title: “Role of pharmacist in boosting health economy: new opportunities”
 

Dr. Islam AnanDr. Islam Anan is leading Accsight offices in the Middle East and Africa for the 3 business units (Accsight HIS) Marketing Research, Market Access, HEOR and Real World Evidence Research, (Accsight PSP).
He is Course Instructor for Economic Evaluation in the Health Economics Diploma and lecturer of Pharmacoeconomics and Health Care Marketing
Title: “COVID-19 Wave preparedness plan”

Engineer Yousry Atlm
Title: Intelligent Healthcare

Engineer Medhat MahmoudEng. Medhat is a core member in Huawei’s global Digital Transformation Office. He is a senior ICT and IoT global industry expert who has led successful projects and digital transformation initiatives with the major international ICT industry leaders and held various senior positions, managing global assignments in North America, MEA, and APAC.
Title: Intelligent Healthcare

Workshop

Published in Conference
Wednesday, 02 December 2020 08:28
3038 Hit
(2 votes)

Mohamed Abd Allah Salem (PhD)Mohamed Abd Allah Salem (PhD), Lecturer,Pharmacognosy Department, Faculty of Pharmacy, Menoufia University
Title “MS-based metabolomics applications in pharmacy”

Description
Understanding of complex biological systems requires the measurement, analysis and integration of multiple compound classes of the living cell, usually determined by transcriptomic, proteomic and metabolomics measurements. Metabolomics studies aim for the identification and quantification of the complement of all small molecules and lipids within a biological system.
In recent years, metabolomics has emerged as cornerstones in the field of systems biology. This workshop will provide the participants with: Introduction to ‘omics’ technologies Experimental design and sample preparation in metabolomics studies MS-based metabolomics analysis Multivariate data analysis

To be eligible for this workshop you need to:
Have some basic experience in practical/theoretical gas/liquid chromatography (GC/LC) and mass spectrometry (MS).
Have a master’s degree or similar.

Eman Gomaa (PhD)Eman Gomaa (PhD) Associate Professor of Biochemistry Department. Faculty of Pharmacy, MSA University. M.Sc. Fellow of Copenhagen University (Panum Institute), Denmark Ph.D. Fellow of the Technical University in Munich (Klinikum rechts der Isar), Germany Postdoctoral fellow of Mount Sinai School of Medicine, NY, USA. Postdoctoral fellow of Pierre et Marie Curie University, ParisVI - Currently Sorbonne, (L’Hopital Salpetrier Medical School), Paris, France
Title: “Genetic Toxicology: A Regulatory Requirement in the Discovery and Development of New Pharmaceuticals”

Description:
Genetic toxicology data is used as an alternate for long-term carcinogenicity data during early drug development. It represents an important part of preclinical safety assessment of new drugs and is required prior to Phase I/II clinical trials. It is designed to identify potentially hazardous drug candidates by detecting their genetic damage such as gene mutations and chromosomal aberration, which may be reflected in tumorigenic or heritable mutation potential of the drug. Learning Outcomes:
Participants in this workshop will gain knowledge about the following:
- Introduction to genetic toxicology and its impact on drug discovery and development
- Differences between genotoxicity, mutagenicity and cytotoxicity
- Principle, procedures and data analysis of different techniques used in genetic toxicology during the process of drug development
- Single cell gel electrophoresis assay
- Methods for detection of chromosomal aberrations
- Micronucleus test

To be eligible for this workshop you need to:
Pharmacy graduates interested in genetics and toxicology.  

Marwa Hamdi (PhD) and Omar El Kady (PhD)
Marwa Hamdi (PhD) and Omar El Kady (PhD) ,Lecturer,Pharmaceutics Department, Faculty of Pharmacy,MSA University
Title: “Concomitant Application of Quality by Design and Artificial Intelligence in Drug Delivery”

Description:
Quality by Design (QbD) is an industry initiative supported by regulators. However, it is also a systematic method of process development which delivers consistency, robustness and increased process knowledge. QbD is certainly becoming a scientific, risk based proactive approach to pharmaceutical product development. Artificial intelligence can be potentially used to create the multidimensional interactions of input variables and to closely bind these variables to a design space.
Goal
This workshop will provide the participants with:
- Comprehensive understanding of QbD including current uses and promised use
- The overall logic and flow of the QbD development process, which includes the use and application of the various tools
- Development and use of Quality Target Product Profiles (QTPPs)
- Definition and verification of Critical Quality Attributes (CQAs), Critical Material Attributes (CMAs) and Critical Process Parameters (CPPs)
- Facets of statistical design of experiments (DOEs), using different response surface methodologies and artificial intelligence technique.
- Design Space and its application in process control, lifecycle management, understanding design space limits.
- Development and optimization of process control strategies.
- Direct application of the steps of QbD and artificial intelligence in the drug formulation.

To be eligible for this workshop you need to:
Have some basic knowledge on statistical analysis

Amira Abdeldaim (PhD)Amira Abdeldaim (PhD), Lecturer of Biochemistry, Faculty of Pharmacy, MSA University. Postdoctoral researcher in The AIDS research center, Kunamoto University, Japan Postdoctoral researcher in the International research center for medical sciences (IRCMS), Kunamoto University, Japan.
Title: “Advanced Technologies for stem cell research”

Description
During this workshop, we will discuss different technologies utilized in the stem cell research to analyse the cell differentiation and explore the mechanisms controlling cell differentiation and self-renewability.

To be eligible for this workshop you need to:
With background of molecular biology and stem cell biology

SchrodingerSchrödinger
Title: “Introduction to Structure-Based Drug Design”

Description
This workshop is powered by Schrödinger’s industry-leading computational platform to accelerate drug discovery and materials design is deployed by leading biopharmaceutical and industrial companies, academic institutions and government laboratories worldwide. Schrödinger is also applying its computational platform to a diverse and extensive pipeline of drug discovery programs in collaboration with pharmaceutical companies and has co-founded leading biotech companies.
In addition, Schrödinger is using its platform to advance a pipeline of internal, wholly-owned drug discovery programs. It will include 1-hour live demo and the distribution of evaluation licenses for an opportunity to try out the Schrödinger's drug discovery suite “Maestro”.

To be eligible for this workshop you need to:
Pharmacy Postgraduates with interest in medicinal chemistry

Zeinab KamelZeinab Kamel-, Microbiology and Immunology Department, Faculty of Pharmacy, MSA University.
Title:“Gene expression (RNA Seq) analysis using R programming language”

Description:
The workshop will briefly discuss and provide hands-on practice with RNA sequencing and analysis using computational biology and bioinformatics. An overview will be given on the fundamentals of OMICs based sciences, in particular, transcriptome. The main steps of RNA-sequencing and analysis workflow will be highlighted, including; cDNA library preparation, a quality check of fastq files, genome alignment, and identification of differentially expressed genes.
Learning outcomes:
- By the end of this workshop, the participants will be able to:
- Understand fundamentals of molecular biology and transcriptomes.
- Outline the required steps of RNA-seq analysis workflow.
- Recognize and distinguish between different parts of Rstudio.
- Run a script and interpret results of data analysis on Rstudio.
- Annotate the expressed genes on web-based tools (Gprofiler or GSEA).

To be eligible for this workshop you need to:
Have some basic knowledge of OMICs-based science
Know the fundamentals of R programming language

Mostafa AwwadMostafa Awwad Cardiovascular Renal Metabolic Marketing Manager. AstraZeneca
Title: “Marketing in Pharmaceutical Companies”

Program Booklet

Published in Conference
Sunday, 29 September 2019 10:36
4551 Hit
(1 Vote)

Call for Submission

Published in Conference
Monday, 23 September 2019 10:30
2914 Hit
(1 Vote)

MSA University - Translating Cultures: Theory and Practice

Call for Submission:
The conference features presentations and posters.

You are invited to send an abstract of 250-300 words to the following email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Deadline for sending abstracts: 30th June, 2019

Acceptance notification: 11th July, 2019 (Abstracts are subject to a peer-review process)

 

Registration fees for presenters:

250 EGP for Egyptians

100$ for non-Egyptians
 

Registration fees for attendees:

150 EGP for Egyptians (Including a certificate of Attendance)

50$ for non-Egyptians

 

• Registration fees cover conference material, coffee breaks and refreshments for the two days.

• For any inquiries, send an email to This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Keynote Speakers

Published in Conference
Monday, 23 September 2019 09:50
4383 Hit
(1 Vote)

Prof. Mary MalcolmProfessor Mary Malcolm, Deputy Vice Chancellor (Academic), University of Bedfordshire, UK Opening Ceremony Keynote Speaker PPT Title: “Last in Translation: The Promise and Practice of a Research-Teaching Nexus” - At University of Bedfordshire, Professor Malcolm has overall responsibility for the quality of the learning experience, including the work of the Centre of Learning Excellence to integrate into the curriculum the knowledge and skills that support enterprise, environmental sustainability, and global citizenship. - She further has a leading role in partnership development (UK and overseas), quality assurance and organizational development.

Dr. Omid TofighianDr. Omid Tofighian-
Assistant Professor, Philosophy – Department of Philosophy, School of Humanities and Social Sciences- AUC. Second Day Keynote Speaker PPT Title: “Refugee Filmmaking and the Border-Industrial Complex” - Omid Tofighian is an award-winning lecturer, researcher and community advocate, combining philosophy with interests in citizen media, popular culture, displacement and discrimination. He contributes to community arts and cultural projects and works with refugees, migrants and youth. - Tofighian has taught at different universities in Australia, the United Arab Emirates, Belgium, the Netherlands & Egypt. He has published numerous book chapters and journal articles.
 

Prof. Nadia El-KholyProf. Nadia El Kholy, Professor of English Language & Literature at Cairo University PPT Title: “The Fairy Tale and Translation: Is there an Egyptian Cinderella?” - University of Bedfordshire External Examiner at MSA University-Faculty of Languages - Nadia El Kholy was the Cultural Counsellor at the Egyptian Embassy in London from 2012-2015. She served as Director of the National Council for Children’s Culture, was a member of the jury for the Hans Christian Anderson international award for Children's Literature and is currently a member of the IBBY (international Board of Books for Young Readers) Executive Committee as well as President of the Egyptian Board of Books for Young Readers (EBBY). - Her research interests include writing and translation for children, Comparative and Postcolonial Literature, and Gender Studies.

Prof. Mustafa RiadProf. Mustafa R M Riad, Professor of English Literature, Faculty of Languages, MSA University PPT Title: “Ethical and Social Responsibility in the Practice of Translation: A Case Study of Egyptian Translators in Modern Times” - Professor Riad's research interests include comparative studies and translation. He is a translator and editor of several works and studies in literature and the humanities. Published papers and took part in conferences in Egypt and abroad in the fields of theatre and translation. He is the Ex- Editor-in-chief of Al Masrah (Theatre) magazine published by the General Egyptian Book Organization. And an esteemed expert in the Literature Committee of the Academy of the Arabic Language.

Translating Cultures: Theory and Practice

Published in Conference
Wednesday, 08 May 2019 11:47
17100 Hit
(1 Vote)

MSA University - Translating Cultures: Theory and Practice

Call for Papers:
The Faculty of Languages, MSA University is pleased to launch its first international conference “Translating Cultures: Theory and Practice” in October 2019.

 

The conference offers an engaging platform for academicians, theorists, artists and practitioners from different backgrounds to share their ideas on how languages and narratives can be diversely understood across different cultures and contexts.

 

The conference aims to highlight the role of cultures and/or cultures in translation in enlightening people and transmitting diverse values, narratives and histories. This enlightenment contributes to a level of understanding that leads to appreciation, tolerance, acceptance and inter/cross-cultural communication.

Publication Opportunity

Dear Colleagues

 

Please be advised that there would be a publication opportunity for the BEST 15 to 20 papers in a book adopted from the conference which will be published by Cambridge Scholar Publishing within a year after the end of the conference.

 

The Deadline for sending abstracts is thereby extended to June 30, 2019

Topics of Interest:
Topics of interest include, but are not limited to, the following:

1- Challenges of Cultural Translation
2- Transnationalism
3- Intercultural Encounters
4- Performing Cultures
5- History and Culture in Literary Texts
6- Translating History between Theory and Practice
7- Translation and Media
8- Culture and Education
9- Culture and Arts
10- Localization and Globalization
11- Language and Cultural Transformations
12- Multiculturalism and identity
13- Sociocultural Contexts in Teaching EFL
14- Digital Humanities
15- Cyber Culture